Kura Oncology KURA 深 滬
等待開盤 09-25 09:30:00 美东时间
10.86
-0.180
-1.63%
華盛通- 最 高11.075
- 今 開11.00
- 成交量 177.16万股
- 最 低 10.66
- 昨 收 11.04
- 總市值 9.66亿
- 52周最高 13.90
- 市盈率 靜 --
- 換手率 1.99%
- 52周最低 7.3575
- 委 比 2.23%
- 總股本 8896.06万
- 歷史最高 43.00
- 量 比 0.83
- 振 幅 3.76%
- 歷史最低 2.50
- 每 手 1
- 風險率 1.31%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kura Oncology Appoints Jennifer Fulk As CFO, Effective September 8
– Seasoned public company CFO with deep biopharmaceutical finance experience across commercial operations, R&D portfolio management, investor relations, and capital allocation – SAN DIEGO, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA, "Kura"))), a biopharmaceutical company fo...
09-08 19:05
Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer
Kura Oncology appoints Jennifer Fulk as Chief Financial Officer, effective September 8, 2026. With over 20 years of experience in biopharmaceutical finance, Fulk previously held senior roles at Eli Lilly, Talkspace, and Soleno Therapeutics. Her expertise in commercial operations, R&D portfolio management, and investor relations is expected to support Kura's growth and value creation. Fulk will oversee capital allocation and execution to maximize ...
09-08 11:00
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Kura Oncology granted inducement stock options to four new employees under its 2023 Inducement Option Plan, allowing them to purchase 48,450 shares of common stock. The options, exercisable at $12.89 per share, vest over four years, with 25% vesting after one year and the remainder vesting monthly over the next 36 months. The grant aligns with Nasdaq Listing Rule 5635(c)(4) and is subject to the terms of the Company’s 2023 Inducement Option Plan ...
09-04 11:30
KURA jumps 9% after CEO purchases 100,000 shares
Kura Oncology (KURA) stock price jumped ~8.7% after President and CEO Troy Wilson purchased 100,000 shares of the cancer drug developer. Wilson bought the shares on August 17 at a weighted average pri...
08-25 18:02
美股大行评级 | 首予买入！Jersey Mike's获13家大行评级；大摩、富国银行齐上调迈威尔科技目标价，最高升至310美元
今日重点评级关注：Truist Securities：维持CoreWeave"买入"评级，目标价从155美元升至165美元；百德：维持亚德诺"跑赢大市"评级，目标价从450美元升至675美元
08-25 11:47
Duos Technologies Posts Upbeat Q2 Results, Joins Amylyx Pharmaceuticals, Weave Communications And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were lower, with the Nasdaq Composite falling over 300 points on Tuesday. Shares of Duos Technologies Group Inc (NASDAQ:DUOT) rose sharply as the company reported better-than-expected second-quarter financial results. Duos Technologies reported quarterly earnings of $1.37 per share which...
08-18 22:11
Kura Oncology rises after hours on large CEO share purchase
Kura Oncology (KURA) is up ~5% in after-hours trading Monday following the disclosure CEO Troy Wilson bought 100,000 shares through a trust. One Fish Two Fish Revocable Trust acquired the shares on Mo...
08-18 05:31
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Barclays Reaffirms Their Buy Rating on Kura Oncology (KURA)
Barclays analyst Etzer Darout maintained a Buy rating on Kura Oncology today an...
08-13 16:26
Kura Oncology Q2 EPS $(0.77) Beats $(0.87) Estimate, Sales $20.874M Miss $21.420M Estimate
Kura Oncology (NASDAQ:KURA) reported quarterly losses of $(0.77) per share which beat the analyst consensus estimate of $(0.87) by 11.49 percent. This is a 2.67 percent decrease over losses of $(0.75) per share from the same period last year. The company reported quarterly sales of $20.874 million w...
08-13 04:03
